Quick Answer
Larimar Therapeutics, Inc. reported Shares Outstanding of 83.09 million shares for fiscal year 2025.
Larimar Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 83.09M | +30.2% |
| 2024 | 63.82M | +45.3% |
| 2023 | 43.91M | +1.5% |
| 2022 | 43.27M | +144.3% |
| 2021 | 17.71M | +15.2% |
| 2020 | 15.37M | +152.3% |
| 2019 | 6.09M | -83.7% |
| 2018 | 37.29M | +35.6% |
| 2017 | 27.49M | +0.6% |
| 2016 | 27.33M | +0.3% |
| 2015 | 27.24M | +19.1% |
| 2014 | 22.88M | +3036.7% |
| 2013 | 729,391 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 85.59M | +34.1% | +33.7% |
| June 30, 2025 | 64.03M | +0.4% | +0.0% |
| March 31, 2025 | 64.03M | +0.4% | +0.3% |
| December 31, 2024 | 63.82M | +45.3% | +0.0% |
| September 30, 2024 | 63.81M | +45.3% | +0.0% |
| June 30, 2024 | 63.80M | +47.5% | +0.0% |
| March 31, 2024 | 63.80M | +47.4% | +45.3% |
| December 31, 2023 | 43.91M | +1.5% | +0.0% |
- Larimar Therapeutics, Inc. showed an increase of +30.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Larimar Therapeutics, Inc.’s shares outstanding has grown by 11291.7% (from 729.4 thousand shares to 83.09 million shares).
- The most recent figure is from Larimar Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: